Anupam Rasayan is in the limelight today morning, opening with a slight gap upwards, rising over 4% to Rs.799; profit booking at this stage has pulled down to the stock to Rs.773 levels, where it is currently ruling. Its 52-week is at Rs.849.70, hit on 15th May.

Without naming the companies who placed the order, the company today morning announced that it has received Rs 540 crores from two renowned multinational companies dealing in the fields of life sciences chemicals.

The tenure of the contract is for five years where life sciences related specialty chemicals will be provided to them by the company.

A couple of weeks back, it had received an order worth Rs 1,100 crore from a multinational life sciences company.

Prior to that, on April 12, the company said it has re-paid certain identified borrowings aggregating to Rs 470.73 crore as on March 31, 2021 of its total outstanding debt from the net proceeds of its recently completed IPO.

And on 5th May, Plutus Wealth Management purchased 1 million shares, representing 1% stake in the company at Rs 647.30/share through a bulk deal on the BSE.

The stock got listed on the BSE on 24th March’21 and it was at discount – listed at Rs.534 v/s IPO price of Rs.555.